Landmark analyses in patients with PET that was negative at the end of immunochemotherapy according to the administration of RT consolidation or not. OS (n = 272) (A) and PFS (n = 272) (B) of the whole cohort; OS (n = 171) (C) and PFS (n = 171) (D) of patients with extranodal involvement.